Table 4.

Formulation of paclitaxel with PLGA, 0.05% SLS and PVA.

NO	Code	D:P (mg)	Size (nm)	PDI	Z.P (mv)	Amount Encapsulate (mg/mL)	(%) E.E	(%) Drug Loading
PVA (0.5%)
01	PTX 67	1:10	289 ± 0.12	0.3 ± 0.01	−4 ± 0.5	0.81	81%	8.1
02	PTX 68	2:10	378 ± 22.11	0.9 ± 0.04	−7 ± 0.3	1.1	55%	11
03	PTX 69	3:10	528 ± 12.3	1.0 ± 0.05	−3 ± 0.4	2.94	98%	29.4
04	PTX 70	4:10	620 ± 11.1	0.3 ± 0.01	−7 ± 0.5	3.88	97%	38.8
PVA (1%)
05	PTX 72	1:10	244 ± 0.19	0.3 ± 0.02	−3 ± 0.2	0.78	78%	7.8
06	PTX 73	2:10	349 ± 12.08	0.5 ± 0.03	−4 ± 0.6	1.92	96%	19.2
07	PTX 74	3:10	327 ± 23.2	0.7 ± 0.03	−2.20 ± 0.3	2.52	84%	25.2
08	PTX 75	4:10	365 ± 10.91	0.6 ± 0.04	−5.11 ± 0.4	3.80	95%	38
PVA (1.5%)
09	PTX 76	1:10	408 ± 26.13	0.2 ± 0.02	−3.25 ± 0.2	0.94	94%	9.4
10	PTX 77	2:10	496 ± 7.09	0.3 ± 0.01	−3.71 ± 0.1	0.19	95%	1.9
11	PTX 78	3:10	1042 ± 11.1	1.0 ± 0.04	−7.75 ± 0.6	2.91	97%	29.1
12	PTX 79	4:10	1040 ± 0.19	1.0 ± 0.05	−4.31 ± 0.5	3.84	96%	38.4
PVA (2%)
13	PTX 80	1:10	315 ± 18.45	0.3 ± 0.01	−2.23 ± 0.3	0.94	94%	9.4
14	PTX 81	2:10	402 ± 23.66	0.6 ± 0.02	−1.53 ± 0.2	1.84	92%	18.4
15	PTX 82	3:10	529 ± 34.24	0.9 ± 0.01	−1.15 ± 0.1	2.64	88%	26.4
16	PTX 83	4:10	601 ± 43.21	0.5 ± 0.03	−1.1 ± 0.1	3.36	84%	33.6

D: Paclitaxel, P: PLGA.